Amino acid analogs as CCK antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – N-c doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514487, 560 27, 560 28, A61K 3127, C07C27110

Patent

active

053310063

ABSTRACT:
Novel unnatural dipeptoids useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, or as antipsychotics are disclosed. Further, the compounds are antianxiety agents and antiulcer agents. The compounds are agents useful for preventing the response to withdrawal from chronic treatment or use of nicotine, diazepam, alcohol, cocaine, caffeine, and opioids. The compounds are also useful in treating and/or preventing panic attacks. Also disclosed are pharmaceutical compositions and methods of treatment using the dipeptoids as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject compounds to prepare diagnostic compositions.

REFERENCES:
patent: 4241064 (1980-12-01), Matsumura et al.
patent: 4705856 (1987-11-01), Biere
Thaisrivongs et al "Renin Inhibitory Peptides: A Study of Structural Modifications in the Peptide Backbone" CA 111:89774m (1989).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Amino acid analogs as CCK antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amino acid analogs as CCK antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid analogs as CCK antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-520345

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.